Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 228 participants.
Also called NCT07119372
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 228 participants
- Sponsor
- Registry
-
NCT07119372
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07119372. Randomized; no masking; primary purpose treatment. Start 2025-03-01 (actual); primary completion 2026-05-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- Condition
- Anemia
- Condition
- Chronic Kidney Disease
- Condition
- Chronic Kidney Disease Patients on Hemodialysis
- Condition
- Chronic Kidney Disease 5D
- Intervention (Biological)
- BCD-131 (pegdarbepoetin beta)
- Intervention (Biological)
- Mircera (methoxypolyethylene glycol-epoetin beta)
- Lead sponsor
- Biocad
Record details
- Record id
cardio:ct-nct07119372- Content hash
a8f3ba90fe3d1ea2daf54a9fb8dd5f158af6037a64546e6274d7e93ad6b410e8